Biodegradable implants

2024: Rosatom bought the rights to develop biodegradable implants for 253 million rubles

On August 9, 2024, it became known that Rosatom State Corporation, through its RuSat RDS division, which deals with civilian products, acquired the exclusive rights to develop biodegradable fastening implants for ₽253 million. These implants were created in collaboration with the Kurchatov Institute Research Center.

The total cost of the project, including development costs, is ₽468 million. As part of the project, screws, plates and rods from innovative copolymers of lactide and calcium phosphate fillers were developed. These materials allow patients using such implants to undergo MRIs safely, improve engraftment and reduce the risk of side effects such as cysts and inflammation without causing bone degradation.

Unclinic

R&D (R&D) for the development of copolymers and the production of a pilot version of implants was announced as a division "Science and innovation" of Rosatom State Corporation in October 2023. Then the maximum contract price was ₽215 million, and it was assumed that medical devices would be used in traumatology, orthopedics and maxillofacial surgery.

In August 2024, RuSat RDS placed a purchase for the acquisition of all exclusive development rights from the contractor, the Kurchatov Institute Research Center. As part of the contract, the winner of the competition was to evaluate the raw materials for the production of implants on the market of Russia and friendly countries, develop laboratory regulations for their production, as well as conduct technical and biomedical tests of prototypes of medical devices.

RuSat RDS is Rosatom's industry integrator in the production of machinery and electronics. The Kurchatov Institute Research Center plays a key role in the implementation of the roadmap for nuclear medicine and is the operator of the synchrotron network development program in Russia.^[1]

Notes